Clinical trials
Phase 3 Alzheimer Disease trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 5 |
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| GlaxoSmithKline | 3 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| AB Science | 1 |
| Eisai Co., Ltd. | 1 |
| Janssen Research & Development, LLC | 1 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 1 |
| Novo Nordisk A/S | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Prof Brian Lawlor | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 16 |
| Dementia | 4 |
| Cognitive Dysfunction | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Amyloidosis | 2 |
| Cardiomyopathies | 2 |
| Heart Diseases | 2 |
| Memory Disorders | 2 |
| Psychomotor Agitation | 2 |
| Cerebrovascular Disorders | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.